Cargando…

Fatigue and Muscle Atrophy in a Mouse Model of Myasthenia Gravis Is Paralleled by Loss of Sarcolemmal nNOS

Myasthenia Gravis (MG) patients suffer from chronic fatigue of skeletal muscles, even after initiation of proper immunosuppressive medication. Since the localization of neuronal nitric oxide synthase (nNOS) at the muscle membrane is important for sustained muscle contraction, we here study the local...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meinen, Sarina, Lin, Shuo, Rüegg, Markus A., Punga, Anna Rostedt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429452/ https://www.ncbi.nlm.nih.gov/pubmed/22952904 http://dx.doi.org/10.1371/journal.pone.0044148

Ejemplares similares

Epidemiology of Myasthenia Gravis in Sweden 2006–2016
por: Westerberg, Elisabet, et al.
Publicado: (2020)

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine
por: Sabre, Liis, et al.
Publicado: (2020)

Editorial: Advances in Autoimmune Myasthenia Gravis
por: Punga, Anna Rostedt, et al.
Publicado: (2020)

A Hypothesis for Examining Skeletal Muscle Biopsy-Derived Sarcolemmal nNOSμ as Surrogate for Enteric nNOSα Function
por: Chaudhury, Arun
Publicado: (2015)

Myasthenia Gravis and Physical Exercise: A Novel Paradigm
por: O'Connor, Laura, et al.
Publicado: (2020)

Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients
por: Molin, Carl Johan, et al.
Publicado: (2017)

Commentary: A Hypothesis for Examining Skeletal Muscle Biopsy-Derived Sarcolemmal nNOSμ as Surrogate for Enteric nNOSα Function
por: Percival, Justin
Publicado: (2015)

Botulinum toxin injections associated with suspected myasthenia gravis: An underappreciated cause of MG-like clinical presentation
por: Punga, Anna Rostedt, et al.
Publicado: (2020)

Thymectomy lowers the myasthenia gravis biomarker miR-150-5p
por: Molin, Carl Johan, et al.
Publicado: (2018)

In vivo requirement of the α-syntrophin PDZ domain for the sarcolemmal localization of nNOS and aquaporin-4
por: Adams, Marvin E., et al.
Publicado: (2001)

Dystrophin R16/17-syntrophin PDZ fusion protein restores sarcolemmal nNOSμ
por: Patel, Aman, et al.
Publicado: (2018)

Muscle fatigue, nNOS and muscle fiber atrophy in limb girdle muscular dystrophy
por: ANGELINI, CORRADO, et al.
Publicado: (2014)

Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs
por: Fiorillo, Alyson A., et al.
Publicado: (2020)

Dystrophin R16/17 protein therapy restores sarcolemmal nNOS in trans and improves muscle perfusion and function
por: Zhao, Junling, et al.
Publicado: (2019)

The impact of physical exercise on neuromuscular function in Myasthenia gravis patients: A single-subject design study
por: Westerberg, Elisabet, et al.
Publicado: (2018)

Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p
por: Beretta, Francesca, et al.
Publicado: (2022)

Extraocular Muscle Atrophy in Myasthenia Gravis
por: Pedapati, Radhakrishna, et al.
Publicado: (2022)

Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries
por: Sabre, Liis, et al.
Publicado: (2017)

Response: “Commentary: A Hypothesis for Examining Skeletal Muscle Biopsy-Derived Sarcolemmal nNOSµ as Surrogate for Enteric nNOSα Function”. nNOS(skeletal muscle) may be Evidentiary for Enteric NO-Transmission Despite nNOSµ/α Differences
por: Chaudhury, Arun
Publicado: (2016)

Functional Deficits in nNOSμ-Deficient Skeletal Muscle: Myopathy in nNOS Knockout Mice
por: Percival, Justin M., et al.
Publicado: (2008)

Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-α2-deficient congenital muscular dystrophy (MDC1A)
por: Meinen, Sarina, et al.
Publicado: (2012)

Fatigue in myasthenia gravis: is it more than muscular weakness?
por: Elsais, Ahmed, et al.
Publicado: (2013)

Eculizumab improves fatigue in refractory generalized myasthenia gravis
por: Andersen, Henning, et al.
Publicado: (2019)

Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling
por: Courtney, Michael J., et al.
Publicado: (2014)

Dual role of nNOS in ischemic injury and preconditioning
por: Barua, Anupama, et al.
Publicado: (2010)

Inhibition of the AMPK/nNOS pathway for neuroprotection in stroke
por: Khan, Mushfiquddin, et al.
Publicado: (2016)

Fatigue in myasthenia gravis: risk factors and impact on quality of life
por: Hoffmann, Sarah, et al.
Publicado: (2016)

Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis
por: Andersen, Henning, et al.
Publicado: (2019)

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial
por: Piehl, Fredrik, et al.
Publicado: (2022)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker
por: Punga, Tanel, et al.
Publicado: (2014)

Characteristics of colonic migrating motor complexes in neuronal NOS (nNOS) knockout mice
por: Spencer, Nick J.
Publicado: (2013)

Pathomechanisms of Paraneoplastic Myasthenia Gravis
por: Ströbel, Philipp, et al.
Publicado: (2003)

Linker molecules between laminins and dystroglycan ameliorate laminin-α2–deficient muscular dystrophy at all disease stages
por: Meinen, Sarina, et al.
Publicado: (2007)

Thymectomy for myasthenia gravis
por: Moorehead, R J, et al.
Publicado: (1985)

Thymectomy in Myasthenia Gravis
por: Dunlop, D. M.
Publicado: (1953)

Cannot write session to /tmp/vufind_sessions/sess_gpo4ink4o43e40thn6at4avn7h